Paliperidone palmitate vs placebo
Leaving the study early · patients with schizophrenia
Paliperidone palmitate leads to lower leaving the study early ‐ any reason Reported by trial author compared with placebo (high certainty).
1 finding from 1 review
- RR 0.76 [7, 84]5 studies · 2183 participantsHigh